We serve Chemical Name:3β,7β,17β-Trihydroxyandrost-5-ene CAS:2697-85-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3β,7β,17β-Trihydroxyandrost-5-ene
CAS.NO:2697-85-0
Synonyms:Androst-5-ene-3,7,17-triol, (3β,17β)-;Androst-5-ene-3b,7,17b-triol;(3β,17β)-Androst-5-ene-3,7,17-triol;Androst-5-ene-3beta,7beta,17beta-triol;3β,7β,17β-Trihydroxyandrost-5-ene;(3beta,7beta,17beta)-Androst-5-ene-3,7,17-triol
Molecular Formula:C19H30O3
Molecular Weight:306.440
HS Code:
Physical and Chemical Properties:
Melting point:235-237 ºC
Boiling point:474.3±45.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.587
PSA:60.69000
Exact Mass:306.219482
LogP:2.05
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Androst-5-ene-3,7,17-triol, (3β,17β)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3beta,7beta,17beta)-Androst-5-ene-3,7,17-triol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Androst-5-ene-3b,7,17b-triol Use and application,(3beta,7beta,17beta)-Androst-5-ene-3,7,17-triol technical grade,usp/ep/jp grade.
Related News: This not only makes it easier to remove enzyme residues from the desired product, but also ensures valuable high turnover enzymes can be reused multiple times without compromising their activity. butyl prop-2-enoate,methyl 2-methylprop-2-enoate,oxiran-2-ylmethyl 2-methylprop-2-enoate,styrene manufacturers “We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab,” Sandrock said. “A better understanding of the facts is good for everyone involved to assure confidence in both the therapy and the process by which it was approved as we prioritize the issues that affect patients.” 3-fluorobutan-2-one suppliers A possible reason for this is that developments within the biocatalysis field have fast outpaced existing knowhow, leaving some pharmaceutical companies unaware of the vast range of options available. Keeping abreast of both current and emerging developments within the field of biocatalytic processing is key when it comes to maintaining a competitive edge. 4-ethoxy-2,5-dimethylfuran-3-one vendor & factory.
